protein

Recombinant Human Chitinase 3-like 2 Protein, CF

5112-CH-050

50 ug

432 USD

5112-CH-050

Recombinant Human Chitinase 3-like 2 Protein, CF

50 ug

The Recombinant Human Chitinase 3-like 2 Protein, CF from R&D Systems is derived from NS0. The Recombinant Human Chitinase 3-like 2 Protein, CF has been validated for the following applications: Bioactivity.

Chitinase 3-like 2

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS.

Unconjugated

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain

Human

40 kDa, reducing conditions

42.2 kDa

CHI3L2

Measured by the ability of the immobilized protein to support the adhesion of FaDu human squamous cell carcinoma cells. When 5 x 104 cells per well are added to rhCHI3L2 coated plates for 30 minutes at 37 ░C, cell adhesion is enhanced in a dose dependent manner with typical ED50 range of 0.7-2.8 ╡g/mL. . Opitimal dilutions should be determined by each laboratory for each application.

<0.01 EU per 1 ╡g of the protein by the LAL method.

Q15782

Bioactivity

Mouse myeloma cell line, NS0-derived human Chitinase 3-like 2 protein Tyr27-Leu390, with a C-terminal 10-His tag

NS0

432 USD

CHI3L2, Chitinase 3 like 2, chitinase 3-like 2, chitinase-3-like protein 2, Chondrocyte protein 39, YKL39, YKL-39YKL39

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.